Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Scholar Rock
< Previous
1
2
3
Next >
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 10, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present New Data Evaluating Apitegromab at 36 Months from the Phase 2 TOPAZ trial at the 2023 Annual Cure SMA Conference
May 08, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 12, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces the Addition of Richard Brudnick to Its Board of Directors
April 10, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 15, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports Full Year 2022 Financial Results and Highlights Business Progress
March 07, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present 24-Month Data from the Phase 2 TOPAZ trial at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
March 01, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present at the Cowen 43rd Annual Health Care Conference
February 27, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 17, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer
February 06, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Provides Corporate Update and Highlights Priorities for 2023
January 09, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 15, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports Third Quarter 2022 Financial Results and Highlights Business Progress
November 14, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Recent Phase 1 DRAGON Data Show SRK-181 Continues to be Well Tolerated with Early Indications of Efficacy
November 10, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Appoints Jing L. Marantz, M.D., Ph.D., M.B.A., as Chief Medical Officer
November 09, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Participate in Upcoming Investor Conferences
November 08, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
New Phase 2 TOPAZ Trial Data Indicate Positive Trends in Quality-of-Life Measures Over 24 Months with Apitegromab for Nonambulatory Patients with Types 2 and 3 SMA
October 22, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present Data from the Phase 1 DRAGON trial at the SITC 37th Annual Meeting
October 06, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy
October 04, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 22, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Appoints Jay Backstrom, M.D., M.P.H., to be its Next Chief Executive Officer
September 20, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present at Upcoming ACCP Annual Meeting and World CB & CDx Summit
September 16, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports Second Quarter 2022 Financial Results and Highlights Business Progress
August 08, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces the Addition of Srinivas Akkaraju, M.D., Ph.D. to Its Board of Directors
July 26, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Participate in the 2022 Wedbush PacGrow Healthcare Conference
July 19, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present New Preclinical Data on its Targeted Approach to the LTBP-TGFβ1 Complex for Anti-Fibrotic Therapy at the 2022 FASEB Science Research Conference
July 15, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present Phase 3 SAPPHIRE Trial Design at the 17th International Congress on Neuromuscular Diseases (ICNMD 2022)
July 01, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces $205 Million Registered Direct Offering
June 17, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Positive Phase 2 Topaz Trial Extension Data Demonstrate Sizable and Sustained Motor Function Improvement at 24 Months with Apitegromab for Non-Ambulatory Patients with Types 2 and 3 Spinal Muscular Atrophy (SMA)
June 17, 2022
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.